Renibus Therapeutics is a biotech company, which is dedicated to transforming the cardio-renal disease treatment paradigm by focusing on the prevention and treatment of kidney disease. It pharmacologic intervention combining stannous protoporphyrin and iron sucrose, which induces a preconditioning protective effect on the kidney. The company upregulates production of protective proteins to prevent AKI during cardiac surgery.